Gonadal Mesenchymal Stem Cell Isolation for Low-Rejection Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating and utilizing mesenchymal stem cells (MSCs) for medical treatment are limited by the availability and efficacy of sources, with existing sources like bone marrow and umbilical cord tissue having limitations in quantity and safety, and there is a need for more effective and diverse applications of MSCs in treating various medical conditions.
Innovation Solution
The isolation and utilization of gonadal mesenchymal stem cells (GMSCs) for treating a wide range of medical conditions, including systemic and local administration of GMSCs, their derived vesicles, and conditioned media, which are genetically modified or not, to treat conditions such as musculoskeletal, neurological, ophthalmic, and autoimmune disorders, among others, with minimal rejection and inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If bone marrow is used as the source of MSCs, then the cells can be obtained and utilized for treatment, but the quantity available is limited and the collection process carries potential risks
Solution Approach 1:
The patent extracts MSCs from an alternative source (adipose tissue) rather than the traditional bone marrow source. This extraction from a different location avoids the limitations and risks associated with bone marrow collection while providing adequate quantities of MSCs for therapeutic use.
Solution Approach 2:
The patent changes the source parameter from bone marrow to adipose tissue. This parameter change fundamentally alters the characteristics of the obtained MSCs, providing both sufficient quantity and improved safety profile while maintaining the therapeutic functionality of the cells.
2Adaptability or versatility
If traditional MSC sources are used, then treatment can be provided, but the range and effectiveness of treatments for various medical conditions are limited
Solution Approach 1:
The patent demonstrates that adipose tissue-derived MSCs possess universal applicability across multiple medical conditions including musculoskeletal disorders, neurological conditions, autoimmune diseases, and organ-specific pathologies. This multi-functionality expands the range of treatable conditions while maintaining reliable therapeutic efficacy.
Solution Approach 2:
The patent highlights the dynamic properties of adipose tissue-derived MSCs, including their ability to differentiate into multiple cell lineages and their adaptability to various tissue environments. This dynamic capability enhances treatment versatility across different medical conditions while ensuring reliable outcomes.
Data Source
AI summary
A method for the isolation of cells in animal gonadal tissue. These stem cells can be used in a variety of treatments where these specific stem cells work.